Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

87.80 +10.71 (+13.89%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Why Glaukos Stock Zoomed Almost 14% Higher on Thursday
The company's recent past featured robust growth, and it anticipates continued rises into the near future. 
Via The Motley Fool
Glaukos (GKOS) Q3 2025 Earnings Call Transcript
Glaukos (GKOS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Get insights into the top gainers and losers of Thursday's pre-market session.
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
Earnings Scheduled For October 29, 2025
 
Via Benzinga
Expert Outlook: Glaukos Through The Eyes Of 4 Analysts
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Earnings Scheduled For July 30, 2025
 
Via Benzinga
Why Glaukos Stock Jumped Over 20% After-Hours Today
Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance. 
Via Stocktwits
What's going on in today's after hours session
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
Glaukos Corp (NYSE:GKOS) Soars on Strong Q3 2025 Earnings Beat and Robust 2026 Outlook
Glaukos (GKOS) smashed Q3 2025 earnings forecasts, sending its stock soaring. The company posted record revenue and raised its 2025 and 2026 sales guidance. 
Via Chartmill
Topics Earnings
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Glaukos Announces Third Quarter 2025 Financial Results
From Glaukos Corporation
Via Business Wire
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
 
Via Benzinga
Glaukos Announces FDA Approval of Epioxa™
From Glaukos Corporation
Via Business Wire
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
From Glaukos Corporation
Via Business Wire
Expert Outlook: Glaukos Through The Eyes Of 7 Analysts
 
Via Benzinga
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
From Glaukos Corporation
Via Business Wire
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
From Glaukos Corporation
Via Business Wire
Glaukos Announces Participation in Wells Fargo Healthcare Conference
From Glaukos Corporation
Via Business Wire
Glaukos (GKOS) Q2 Revenue Jumps 30%
Via The Motley Fool
Glaukos Announces Second Quarter 2025 Financial Results
From Glaukos Corporation
Via Business Wire
Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30
From Glaukos Corporation
Via Business Wire
Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies
From Glaukos Corporation
Via Business Wire
Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell
From Glaukos Corporation
Via Business Wire
Glaukos Announces Participation in Upcoming Investor Conferences
From Glaukos Corporation
Via Business Wire
What 11 Analyst Ratings Have To Say About Glaukos
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.